Lecap Asset Management Ltd. Purchases 2,974 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Lecap Asset Management Ltd. grew its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 33.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 11,955 shares of the medical device company’s stock after purchasing an additional 2,974 shares during the quarter. Lecap Asset Management Ltd.’s holdings in Cooper Companies were worth $1,099,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Ashton Thomas Securities LLC purchased a new stake in Cooper Companies during the third quarter valued at about $25,000. Covestor Ltd boosted its holdings in Cooper Companies by 144.9% during the 3rd quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock valued at $37,000 after acquiring an additional 200 shares during the period. Brown Brothers Harriman & Co. grew its position in Cooper Companies by 191.0% during the 3rd quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock worth $46,000 after acquiring an additional 275 shares during the last quarter. West Financial Advisors LLC purchased a new position in Cooper Companies in the 4th quarter worth approximately $49,000. Finally, Friedenthal Financial bought a new stake in Cooper Companies in the third quarter valued at approximately $50,000. 24.39% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages have recently issued reports on COO. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a report on Friday, December 6th. Morgan Stanley cut their price target on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a report on Friday, December 6th. StockNews.com cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Wells Fargo & Company increased their target price on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, December 6th. Finally, Citigroup lowered their price target on Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research report on Friday, December 6th. Three investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $117.00.

Cooper Companies Trading Down 1.8 %

NASDAQ COO opened at $93.57 on Friday. The firm has a market capitalization of $18.67 billion, a PE ratio of 47.98, a P/E/G ratio of 2.45 and a beta of 1.00. The stock’s 50 day moving average is $94.99 and its 200 day moving average is $99.73. The Cooper Companies, Inc. has a twelve month low of $84.76 and a twelve month high of $112.38. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, beating analysts’ consensus estimates of $1.00 by $0.04. The firm had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.03 billion. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company’s quarterly revenue was up 9.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.87 EPS. Research analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.